|
|
| Research article summary (published 18 Nov 2002): |
Towards a core curriculum in clinical pharmacology for undergraduate medical students in Europe.
Full Abstract
Undergraduate medical education has been under the spotlight for many years in Europe. In the United Kingdom the General Medical Council, which validates the final medical examination in all UK Medical Schools, has been trying to influence the curriculum for at least the last 50 years. Following their publication of the document "Tomorrow's Doctors" in 1993 many medical schools in the UK have completely changed their curriculum design away from didactic learning and towards an integrated problem-orientated or problem-based approach. There has been concern that, as the process continues, some of the more traditional learning of pharmacology and clinical pharmacology may be lost with nothing to replace it. This manuscript describe two ways of developing a core curriculum for clinical pharmacology. The first uses a drug orientated approach (almost an essential drug list) where drugs are listed according to whether they are essential for students to know about with just over 120 chemical entities; and a shorter list of drugs that students would be expected to know about but not know in any detail. The second approach is a disease-orientated one with three types of disease process:
a list of 67 disease states that students must know how to manage (category M), a list of 158 diseases that students must be able to diagnose (category D) and a list of 36 diseases that students should be aware of. The disease orientated approach, though designed in one EU country (the UK) has been field tested in a second (Germany) with little difficulty in transfer.
Learn Faster Today Improve your study skills
Author information
Author/s: Orme, Michael (M); Frolich, Jurgen (J); Vrhovac, Bozidar (B); Education Sub-Committee of the European Association for Clinical Pharmacology and Therapeutics;
Affiliation: morme(-atsign-)eandthome.demon.co.uk
Journal and publication information
Publication Type: Comparative Study; Journal Article
Journal: European journal of clinical pharmacology (Eur J Clin Pharmacol), published in Germany. (Language: eng)
Reference: 2002-Dec; vol 58 (issue 9) : pp 635-40
Dates: Created 2002/12/16; Completed 2003/05/12; Revised 2006/11/15;
PMID: 12483457, status: MEDLINE (last retrieval date: 11/6/2008)
Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.
External Links for this article (including full text providers, if available):
Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.
This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.
MeSH headings (categories)
This article was linked to the MESH Headings shown below.
|
Related articles
This article has not been indexed for related articles as yet, however you can still use the live related article search links below.
See a large map of 100+ related articles.